For patients with an inborn error of metabolism, such as Gaucher disease and mucopolysaccharidosis, ERT is a well-known therapeutic approach and has already been proven successful (Ferreira and Gahl, 2017). This evidence concerns the gene ELF3 and Gaucher disease.